The Resource Antibiotics : the perfect storm, David M. Shlaes

Antibiotics : the perfect storm, David M. Shlaes

Label
Antibiotics : the perfect storm
Title
Antibiotics
Title remainder
the perfect storm
Statement of responsibility
David M. Shlaes
Creator
Subject
Language
eng
Cataloging source
UKM
http://library.link/vocab/creatorName
Shlaes, David M
Dewey number
615.329
Illustrations
illustrations
Index
index present
LC call number
RM267
LC item number
.S55 2010
Literary form
non fiction
Nature of contents
bibliography
NLM call number
QV 350
http://library.link/vocab/subjectName
  • Antibiotics
  • Drug development
  • Anti-Bacterial Agents
  • Drug Resistance, Microbial
Label
Antibiotics : the perfect storm, David M. Shlaes
Instantiates
Publication
Bibliography note
Includes bibliographical references (p. 101-103) and index
Contents
  • In Our Hospitals, Things are Getting Critical
  • Antibiotic Resistance Plus Toxin Production Equals Death
  • Our Communities are Not Spared
  • Resistance - Summing Up
  • 4.
  • FDA
  • We Need Them, but They Have Become Part of the Problem
  • FDA Increases Clinical Trial Design Stringency and Costs. Companies Abandon Antibiotic Research
  • "Mild" Infections Require Placebo-Controlled Trials - Industry Balks
  • New Antibiotics for Mild Infections are Forced from the Market While Generic Antibiotics are Still Approved in the Absence of Placebo-Controlled Trials
  • 1.
  • Ketek Scandal
  • Pneumonia - The New Frontier. New Trial Requirements for Pneumonia Will Make Approval Much More Difficult and Costly and Sometimes Simply Infeasible
  • FDA Can Change Its Requirements After Completion of a Trial and then Require New Trials for Approval
  • FDA is Regulating Itself Out of the Antibiotics Business
  • We Need Balance and Perspective from the FDA
  • FDA Makes it Difficult for Them to Obtain Good Advice
  • 5.
  • Europe
  • 6.
  • Industry
  • Perfect Storm
  • Antibiotics Form a Cornerstone of the Pharmaceutical Industry
  • Resistance Should Create Opportunities
  • Industry Consolidation Reduces the Effort in Antibiotics
  • Antibiotics are Not Financially Attractive in the Consolidated Industry
  • Industry Takes a Risk-Averse Approach to Its Clinical Trials, but Deprives Us of the Most Important Information
  • Discovery of New Antibiotics is Becoming Harder
  • US Market Share is Stagnant or Shrinking. Will the Industry be Able to Prioritize Ex-US Territories?
  • Research and Development Costs Increase, but Approvals are Down
  • Some Good News for Everyone
  • Antibiotic R&D in Biotech is Stymied by Late Stage Clinical Trial Costs
  • 2.
  • Biotech is Still a High-Risk Proposition
  • 7.
  • Modest Proposals
  • Role of Government
  • Government Loves a Task Force
  • Government Can Play Several Important Roles
  • Transatlantic Taskforce on Antimicrobial Resistance
  • Government-Sponsored Research and Research Tools are Required
  • Industry Incentives Will Probably Also Be Required. Europe is Leading the Way in Thinking Here
  • FDA (and EMEA)
  • Miracle
  • FDA and EMEA Both Must Adapt a More Balanced Approach to Antibiotics. Required Trial Designs Must Be Feasible
  • Do We Want New Antibiotics for Mild Infections? Is Bacterial Bronchitis in the Setting of Chronic Lung Disease a Mild Infection?
  • FDA Must Modify its Guidelines for Clinical Trials in Community Acquired Bacterial Pneumonia
  • FDA Has to Stop Moving the Goal Posts in Mid-Stream
  • FDA Has to Level the Playing Field with Generic Antibiotics
  • Congress Needs to Step Back from the FDA Especially Where Science is Concerned
  • Our Government Needs Access to the Best Advice it Can Get
  • How About a Totally New Approach to Drug Development?
  • Communication Between the Industry and Physicians is Required, but is Becoming More and More Restricted
  • What Should the Industry Be Doing?
  • 3.
  • Current Large PhRMA Model is not Viable. These Giants Need to Divide Themselves into Bite-Size Portions to Survive
  • 8.
  • Conclusions
  • Resistance
  • Basics
  • Antibiotics for Animals and Crops Lead to Resistance for People
Dimensions
24 cm.
Extent
viii, 106 p.
Isbn
9789048190577
Isbn Type
(e-ISBN)
Other physical details
col. ill.
System control number
  • (CaMWU)u2150283-01umb_inst
  • 2262698
  • (Sirsi) i9789048190560
  • (OCoLC)620364836
Label
Antibiotics : the perfect storm, David M. Shlaes
Publication
Bibliography note
Includes bibliographical references (p. 101-103) and index
Contents
  • In Our Hospitals, Things are Getting Critical
  • Antibiotic Resistance Plus Toxin Production Equals Death
  • Our Communities are Not Spared
  • Resistance - Summing Up
  • 4.
  • FDA
  • We Need Them, but They Have Become Part of the Problem
  • FDA Increases Clinical Trial Design Stringency and Costs. Companies Abandon Antibiotic Research
  • "Mild" Infections Require Placebo-Controlled Trials - Industry Balks
  • New Antibiotics for Mild Infections are Forced from the Market While Generic Antibiotics are Still Approved in the Absence of Placebo-Controlled Trials
  • 1.
  • Ketek Scandal
  • Pneumonia - The New Frontier. New Trial Requirements for Pneumonia Will Make Approval Much More Difficult and Costly and Sometimes Simply Infeasible
  • FDA Can Change Its Requirements After Completion of a Trial and then Require New Trials for Approval
  • FDA is Regulating Itself Out of the Antibiotics Business
  • We Need Balance and Perspective from the FDA
  • FDA Makes it Difficult for Them to Obtain Good Advice
  • 5.
  • Europe
  • 6.
  • Industry
  • Perfect Storm
  • Antibiotics Form a Cornerstone of the Pharmaceutical Industry
  • Resistance Should Create Opportunities
  • Industry Consolidation Reduces the Effort in Antibiotics
  • Antibiotics are Not Financially Attractive in the Consolidated Industry
  • Industry Takes a Risk-Averse Approach to Its Clinical Trials, but Deprives Us of the Most Important Information
  • Discovery of New Antibiotics is Becoming Harder
  • US Market Share is Stagnant or Shrinking. Will the Industry be Able to Prioritize Ex-US Territories?
  • Research and Development Costs Increase, but Approvals are Down
  • Some Good News for Everyone
  • Antibiotic R&D in Biotech is Stymied by Late Stage Clinical Trial Costs
  • 2.
  • Biotech is Still a High-Risk Proposition
  • 7.
  • Modest Proposals
  • Role of Government
  • Government Loves a Task Force
  • Government Can Play Several Important Roles
  • Transatlantic Taskforce on Antimicrobial Resistance
  • Government-Sponsored Research and Research Tools are Required
  • Industry Incentives Will Probably Also Be Required. Europe is Leading the Way in Thinking Here
  • FDA (and EMEA)
  • Miracle
  • FDA and EMEA Both Must Adapt a More Balanced Approach to Antibiotics. Required Trial Designs Must Be Feasible
  • Do We Want New Antibiotics for Mild Infections? Is Bacterial Bronchitis in the Setting of Chronic Lung Disease a Mild Infection?
  • FDA Must Modify its Guidelines for Clinical Trials in Community Acquired Bacterial Pneumonia
  • FDA Has to Stop Moving the Goal Posts in Mid-Stream
  • FDA Has to Level the Playing Field with Generic Antibiotics
  • Congress Needs to Step Back from the FDA Especially Where Science is Concerned
  • Our Government Needs Access to the Best Advice it Can Get
  • How About a Totally New Approach to Drug Development?
  • Communication Between the Industry and Physicians is Required, but is Becoming More and More Restricted
  • What Should the Industry Be Doing?
  • 3.
  • Current Large PhRMA Model is not Viable. These Giants Need to Divide Themselves into Bite-Size Portions to Survive
  • 8.
  • Conclusions
  • Resistance
  • Basics
  • Antibiotics for Animals and Crops Lead to Resistance for People
Dimensions
24 cm.
Extent
viii, 106 p.
Isbn
9789048190577
Isbn Type
(e-ISBN)
Other physical details
col. ill.
System control number
  • (CaMWU)u2150283-01umb_inst
  • 2262698
  • (Sirsi) i9789048190560
  • (OCoLC)620364836

Library Locations

  • Albert D. Cohen Management LibraryBorrow it
    181 Freedman Crescent, Winnipeg, MB, R3T 5V4, CA
    49.807878 -97.129961
  • Architecture/Fine Arts LibraryBorrow it
    84 Curry Place, Winnipeg, MB, CA
    49.807716 -97.136226
  • Archives and Special CollectionsBorrow it
    25 Chancellors Circle (Elizabeth Dafoe Library), Room 330, Winnipeg, MB, R3T 2N2, CA
    49.809961 -97.131878
  • Bibliothèque Alfred-Monnin (Université de Saint-Boniface)Borrow it
    200, avenue de la Cathédrale, Local 2110, Winnipeg, MB, R2H 0H7, CA
    49.888861 -97.119735
  • Bill Larson Library (Grace Hospital)Borrow it
    300 Booth Drive, G-227, Winnipeg, MB, R3J 3M7, CA
    49.882400 -97.276436
  • Carolyn Sifton - Helene Fuld Library (St. Boniface General Hospital)Borrow it
    409 Tache Avenue, Winnipeg, MB, R2H 2A6, CA
    49.883388 -97.126050
  • Concordia Hospital LibraryBorrow it
    1095 Concordia Avenue, Winnipeg, MB, R2K 3S8, CA
    49.913252 -97.064683
  • Donald W. Craik Engineering LibraryBorrow it
    75B Chancellors Circle (Engineering Building E3), Room 361, Winnipeg, MB, R3T 2N2, CA
    49.809053 -97.133292
  • E.K. Williams Law LibraryBorrow it
    224 Dysart Road, Winnipeg, MB, R3T 5V4, CA
    49.811829 -97.131017
  • Eckhardt-Gramatté Music LibraryBorrow it
    136 Dafoe Road (Taché Arts Complex), Room 257, Winnipeg, MB, R3T 2N2, CA
    49.807964 -97.132222
  • Elizabeth Dafoe LibraryBorrow it
    25 Chancellors Circle, Winnipeg, MB, R3T 2N2, CA
    49.809961 -97.131878
  • Fr. H. Drake Library (St. Paul's College)Borrow it
    70 Dysart Road, Winnipeg, MB, R3T 2M6, CA
    49.810605 -97.138184
  • J.W. Crane Memorial Library (Deer Lodge Centre)Borrow it
    2109 Portage Avenue, Winnipeg, MB, R3J 0L3, CA
    49.878000 -97.235520
  • Libraries Annex (not open to the public; please see web page for details)Borrow it
    25 Chancellors Circle (in the Elizabeth Dafoe Library), Winnipeg, MB, R3T 2N2, CA
    49.809961 -97.131878
  • Neil John Maclean Health Sciences LibraryBorrow it
    727 McDermot Avenue (Brodie Centre), 200 Level, Winnipeg, MB, R3E 3P5, CA
    49.903563 -97.160554
  • Sciences and Technology LibraryBorrow it
    186 Dysart Road, Winnipeg, MB, R3T 2M8, CA
    49.811526 -97.133257
  • Seven Oaks General Hospital LibraryBorrow it
    2300 McPhillips Street, Winnipeg, MB, R2V 3M3, CA
    49.955177 -97.148865
  • Sister St. Odilon Library (Misericordia Health Centre)Borrow it
    99 Cornish Avenue, Winnipeg, MB, R3C 1A2, CA
    49.879592 -97.160425
  • St. John's College LibraryBorrow it
    92 Dysart Road, Winnipeg, MB, R3T 2M5, CA
    49.811242 -97.137156
  • Victoria General Hospital LibraryBorrow it
    2340 Pembina Highway, Winnipeg, MB, R3T 2E8, CA
    49.806755 -97.152739
  • William R Newman Library (Agriculture)Borrow it
    66 Dafoe Road, Winnipeg, MB, R3T 2R3, CA
    49.806936 -97.135525
Processing Feedback ...